Bispecific Antibodies in Gastric Cancer Therapeutics: New Hope for High Efficacy and Tolerability
Bispecific antibodies represent a new weapon in the solid tumor oncology armamentarium. In gastric cancer, where available targeted therapies are restricted to a minority of patients, bispecific antibodies may provide much needed new targeted options. This commentary discusses the main constructs and targets of bispecific antibodies in development for gastric cancer.
Authors
- Ioannis A. Voutsadakis (ORCID: https://orcid.org/0000-0002-9301-5951)
Publication Details
- Journal
- Discovery Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.24976/discov.med.202537198.123
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00